Wells Fargo Upgrades Fate Therapeutics (FATE) to Outperform
Tweet Send to a Friend
Wells Fargo analyst Jim Birchenough upgraded Fate Therapeutics (NASDAQ: FATE) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
